Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes

BMC Genomics

Volumn 7, Issue , 2006, Pages

  Hu, Valerie W ^a   Frank, Bryan C ^b   Heine, Shannon ^a   Lee, Norman H ^b   Quackenbush, John ^a,b,c  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; SEROTONIN TRANSPORTER;

ARTICLE; AUTISM; CHROMOSOME; COMPUTER MODEL; CONTROLLED STUDY; DISEASE SEVERITY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE MAPPING; GENETIC SCREENING; HUMAN; LANGUAGE DISABILITY; LYMPHOBLASTOID CELL LINE; MONOZYGOTIC TWINS; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PERIPHERAL LYMPHOCYTE; QUANTITATIVE TRAIT LOCUS; TWIN DISCORDANCE; UNINDEXED SEQUENCE; CELL LINE; CHROMOSOME MAP; CYTOLOGY; GENETICS; INFLAMMATION; LYMPHOCYTE; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

AUTISTIC DISORDER; CELL LINE; CHROMOSOME MAPPING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LYMPHOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUANTITATIVE TRAIT LOCI; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; TWINS, MONOZYGOTIC;

EID: 33746858084     PISSN: 14712164     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-7-118     Document Type: Article

References (81)

1. American Psychiatric Association., American Psychiatric Association. Task Force on DSM-IV.: Diagnostic and statistical manual of mental disorders: DSM-IV. 4th edition. Washington, D.C., American Psychiatric Association; 1994:xxvii, 886 p.
2. Crino PB, Henske EP: New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999, 53(7):1384-1390.
3. Bolton PF: Neuroepileptic correlates of autistic symptomatology in tuberous sclerosis. Ment Retard Dev Disabil Res Rev 2004, 10(2):126-131.
4. Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJ, Short MP, Dumars K, Roach ES, Steingold S, Wall S, Blanton SH, Flodman P, Kwiatkowski DJ, Jewell A, Weber JL, Roses AD, Pericak-Vance MA: Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992, 2(1):37-41.
5. Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 1993, 75(7):1305-1315.
6. Kandt RS: Tuberous sclerosis: the next step. J Child Neurol 1993, 8(2):107- 10; discussion 110-1.
7. Mulley JC, Sutherland GR: Integrating maps of chromosome 16. Curr Opin Genet Dev 1993, 3(3):425-431.
8. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ: Identificadon of the tuberous sclerosis gene TSCI on chromosome 9q34. Science 1997, 277(5327):805-808.
9. Henske EP, Ozelius L, Gusella JF, Haines JL, Kwiatkowski DJ: A high-resolution linkage map of human 9q34.1. Genomics 1993, 17(3):587-591.
10. [Epigenetic study of Rett's syndrome as an adequate model for autistic disorders]. Zh Nevrol Psikhiatr Im S S Korsakova 2005, 105(7):4-11.
11. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, Manca A, Korn B, Poustka A, Yu S, Sutherland GR, Mulley JC: Fragile X syndrome without CCG amplification has an FMRI deletion. Nat Genet 1992, 1(5):341-344.
12. Hansen RS, Gartler SM, Scott CR, Chen SH, Laird CD: Methylation analysis of CGG sites in the CpG island of the human FMRI gene. Hum Mol Genet 1992, 1(8):571-578.
13. Lord C, Rutter M, Le Couteur A: Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994, 24(5):659-685.
14. Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, Schopler E: Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 1989, 19(2):185-212.
15. Yonan AL, Palmer AA, Smith KC, Feldman I, Lee HK, Yonan JM, Fischer SG, Pavlidis P, Gilliam TC: Bioinformatic analysis of autism positional candidate genes using biological databases and computational gene network prediction. Genes Brain Behav 2003, 2(5):303-320.
16. Geschwind DH: DNA microarrays: translation of the genome from laboratory to clinic. Lancet Neurol 2003, 2(5):275-282.
17. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270(5235):467-470.
18. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ: High density synthetic oligonucleotide arrays. Nat Genet 1999, 21 (1 Suppl):20-24.
19. Pongrac J, Middleton FA, Lewis DA, Levitt P, Mirnics K: Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res 2002, 27(10):1049-1063.
20. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J: Post-mortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001, 57(9):1618-1628.
21. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, Spielman RS: Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 2003, 33(3):422-425.
22. Sharma A, Sharma VK, Horn-Saban S, Lancet D, Ramachandran S, Brahmachari SK: Assessing natural variations in gene expression in humans by comparing with monozygotic twins using microarrays. Physiol Genomics 2005, 21(1):117-123.
23. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, Kusumi I, Tsujita T, Okazaki Y, Nanko S, Kunugi H, Sasaki T, Kato T: Impaired feedback regulation of XBPI as a genetic risk factor for bipolar disorder. Nat Genet 2003, 35(2):171-175.
24. Mak YT, Hampson G, Beresford JN, Spector TD: Variations in genome-wide gene expression in identical twins - a study of primary osteoblast-like culture from female twins discordant for osteoporosis. BMC Genet 2004, 5(1):14.
25. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T: Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol Psychiatry 2004, 9(4):406-416.
26. Kato T, Iwayama Y, Kakiuchi C, Iwamoto K, Yamada K, Minabe Y, Nakamura K, Mori N, Fujii K, Nanko S, Yoshikawa T: Gene expression and association analyses of LIM (PDLIMS) in bipolar disorder and schizophrenia. Mol Psychiatry 2005.
27. Yang IV, Chen E, Hasseman JP, Liang W, Frank BC, Wang S, Sharov V, Saeed AI, White J, Li J, Lee NH, Yeatman TJ, Quackenbush J: Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol 2002, 3(11):research0062.
28. Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C, Marques C, Ataide A, Miguel T, Borges L, Vicente AM: Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 2004, 9(3):264-271.
29. Bradley SL, Dodelzon K, Sandhu HK, Philibert RA: Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. Am J Med Genet 8 Neuropsychiatr Genet 2005, 136(1):58-61.
30. Lesch KP, Bengell D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274(5292):1527-1531.
31. Hattori Y, Campbell EB, Gross SS: Argininosuccinate synthetase mRNA and activity are induced by immunostimulants in vascular smooth muscle. Role in the regeneration or arginine for nitric oxide synthesis. J Biol Chem 1994, 269(13):9405-9408.
32. Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A: Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 2004, 18(3):377-390.
33. Heneka MT, Schmidlin A, Wiesinger H: Induction of argininosuccinate synthetase in rat brain glial cells after striatal microinjection of immunostimulants. J Cereb Blood Flow Metab 1999, 19(8):898-907.
34. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA: Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57(1):67-81.
35. Wang WJ, Kuo JC, Yao CC, Chen RH: DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 2002, 159(1):169-179.
36. Gupta S: A decision between life and death during TNF-alpha-induced signaling. J Clin Immunol 2002, 22(4):185-194.
37. Frank S, Stallmeyer B, Kampfer H, Schaffner C, Pfeilschifter J: Differential regulation of vascular endotheliall growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells. Biochem J 1999, 338 (Pt 2):367-374.
38. Byrum RS, Goulet JL, Griffiths RJ, Koller BH: Role of the 5-lipoxy-genase-activating protein (FLAP) in murine acute inflammatory responses. J Exp Med 1997, 185(6):1065-1075.
39. Pokharel YR, Yang JW, Kim JY, Oh HW, Jeong HG, Woo ER, Kang KW: Potent inhibition of the inductions of inducible nitric oxide synthase and cyclooxygenase-2 by taiwaniaflavone. Nitric Oxide 2006.
40. Manev H, Uz T, Sugaya K, Qu T: Putative role of neuronal 5-lipoxygenase in an aging brain. Faseb J 2000, 14(10):1464-1469.
41. Manev R, Manev H: 5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders. Crit Rev Neurobiol 2004, 16(1-2):181-186.
42. Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M: The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006.
43. Cohly HH, Panja A: Immunological findings in autism. Int Rev Neurobiol 2005, 71:317-341.
44. Kamholz J, Awatramani R, Menichella D, Jiang H, Xu W, Shy M: Regulation of myelin-specific gene expression. Relevance to CMTI. Ann N Y Acad Sci 1999, 883:91-108.
45. LeBlanc SE, Jang SW, Ward RM, Wrabetz L, Svaren J: Direct regulation of myelin protein zero expression by the Egr2 transactivator. J Biol Chem 2006, 281(9):5453-5460.
46. Connor RM, Key B: Expression and role of Roundabout-I in embryonic Xenopus forebrain. Dev Dyn 2002, 225(1):22-34.
47. Lee JS, Ray R, Chien CB: Cloning and expression of three zebrafish roundabout homologs suggest roles in axon guidance and cell migration. Dev Dyn 2001, 221(2):216-230.
48. Kanwar JR, Harrison JE, Wang D, Leung E, Mueller W, Wagner N, Krissansen GW: Beta7 integrins contribute to demyelinating disease of the central nervous system. J Neuroimmunol 2000, 103(2):146-152.
49. Buhusi M, Midkiff BR, Gates AM, Richter M, Schachner M, Maness PF: Close homolog of LI is an enhancer of integrin-mediated cell migration. J Biol Chem 2003, 278(27):25024-25031.
50. Naus S, Richter M, Wildeboer D, Moss M, Schachner M, Bartsch JW: Ectodomain shedding of the neural recognition molecule CHLI by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death. J Biol Chem 2004, 279(16):16083-16090.
51. Abdolmaleky HM, Thiagalingam S, Wilcox M: Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope. Am J Pharmacogenomics 2005, 5(3):149-160.
52. Petronis A, Gottesman II, Kan P, Kennedy JL, Basile VS, Paterson AD, Popendikyte V: Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull 2003, 29(1):169-178.
53. Petronis A: Epigenetics and bipolar disorder: new opportunities and challenges. Am J Med Genet C Semin Med Genet 2003, 123(1):65-75.
54. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23(2):185-188.
55. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393(6683):386-389.
56. Jablonka E, Lamb MJ: The changing concept of epigenetics. Ann N Y Acad Sci 2002, 981:82-96.
57. Saeed Al, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J: TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34(2):374-378.
58. Quackenbush J: Microarray data normalization and transformation. Nat Genet 2002, 32 Suppl:496-501.
59. Smith M, Filipek PA, Wu C, Bocian M, Hakim S, Modahl C, Spence MA: Analysis of a I-megabase deletion in 15q22-q23 in an autistic patient: identification of candidate genes for autism and of homologous DNA segments in 15q22-q23 and 15q11-q13. Am J Med Genet 2000, 96(6):765-770.
60. Bartlett CW, Goedken R, Vieland VJ: Effects of updating linkage evidence across subsets of data: reanalysis of the autism genetic resource exchange data set. Am J Hum Genet 2005, 76(4):688-695.
61. Shao Y, Cuccaro ML, Hauser ER, Raiford KL, Menold MM, Wolpert CM, Ravan SA, Elston L, Decena K, Donnelly SL, Abramson RK, Wright HH, DeLong GR, Gilbert JR, Pericak-Vance MA. Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am J Hum Genet 2003, 72(3):539-548.
62. A full genome screen for autism with evidence for linkage to a region on chromosome 7q. International Molecular Genetic Study of Autism Consortium. Hum Mol Genet 1998, 7(3):571-578.
63. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Petersen PB, Pingree C, McMahon W, Wong DL, Cavalli-Sforza LL, Kraemer HC, Myers RM: A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999, 65(2):493-507.
64. Serajee FJ, Zhong H, Nabi R, Huq AH: The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 2003, 40(4):e42.
65. Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH: Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry 2004, 9(5):474-484.
66. Bacchelli E, Blasi F, Biondolillo M, Lamb JA, Bonora E, Barnby G, Parr J, Beyer KS, Klauck SM, Poustka A, Bailey AJ, Monaco AP, Maestrini E: Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMPGEFII gene. Mol Psychiatry 2003, 8(11):916-924.
67. Cantor RM, Kono, N, Duvall JA, Alvarez-Retuerto A, Stone JL, Alarcon M, Nelson SF, Geschwind DH: Replication of autism linkage: fine-mapping peak at 17q21. Am J Hum Genet 2005, 76(6):1050-1056.
68. Sultana R, Yu CE, Yu J, Munson J, Chen D, Hua W, Estes A, Cortes F, de la Barra F, Yu D, Haider ST, Trask BJ, Green ED, Raskind WH, Disteche CM, Wijsman E, Dawson G, Storm DR, Schellenberg GD, Villacres EC: Identification of a novel gene an chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics 2002, 80(2):129-134.
69. Wassink TH, Brzustowicz LM, Bartlett CW, Szatmari P: The search for autism disease genes. Ment Retard Dev Disabil Res Rev 2004, 10(4):272-283.
70. Persico AM, D'Agruma L, Zelante L, Militerni R, Bravaccio C, Schneider C, Melmed R, Trillo S, Montecchi F, Elia M, Palermo M, Rabinowitz D, Pascucci T, Puglisi-Allegra S, Reichelt KL, Muscarella, L, Guarnieri V, Melgari JM, Conciatori M, Keller F: Enhanced APOE2 transmission rates in families with autistic probands. Psychiatr Genet 2004, 14(2):73-82.
71. Veenstra-VanderWeele J, Kim SJ, Lord C, Courchesne R, Akshoomoff N, Leventhal BL, Courchesne E, Cook EHJ: Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am J Med Genet 2002, 114(3):277-283.
72. Bradford Y, Haines J, Hutcheson H, Gardiner M, Braun T, Sheffield V, Cassavant T, Huang W, Wang K, Vieland V, Folstein S, Santangelo S, Piven J: Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet 2001, 105(6):539-547.
73. Chen GK, Kono N, Geschwind DH, Cantor RM: Quantitative trait locus analysis of nonverbal communication in autism spectrum disorder. Mol Psychiatry 2005.
74. Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, Wassink TH, Schneider C, Melmed R, Trillo S, Montecchi F, Palermo M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Conciatori M, Marino R, Quattrocchi CC, Baldi A, Zelante L, Gasparini P, Keller F: Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 2001, 6(2):150-159.
75. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 2001, 69(3):570-581.
76. Alarcon M, Yonan AL, Gilliam TC, Cantor RM, Geschwind DH: Quantitative genome scan and Ordered-Subsets Analysis of autism endophenotypes support language QTLs. Mol Psychiatry 2005, 10(8):747-757.
77. Robinson PD, Schutz CK, Macciardi F, White BN, Holden JJ: Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders. Am J Med Genet 2001, 100(1):30-36.
78. Alarcon M, Cantor RM, Liu J, Gilliam TC, Geschwind DH: Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet 2002, 70(1):60-71.
79. [http://www.agre.org].
80. [http://www.tigr.org].
81. [http://www.ingenuity.com].